CALQUENCE vs KISQALI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. CALQUENCE and KISQALI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CALQUENCE	KISQALI
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ACALABRUTINIB	RIBOCICLIB SUCCINATE
Manufacturer	Astrazeneca	Novartis
Dosage forms	Capsule, Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Mantle-Cell Lymphoma	Breast Neoplasms

calquence kisqali

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

ACALABRUTINIB

RIBOCICLIB SUCCINATE

Manufacturer

Astrazeneca

Novartis

Dosage forms

Capsule, Tablet

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Mantle-Cell Lymphoma

Breast Neoplasms

Frequently asked questions

Which is better-rated, Calquence or Kisqali?

Calquence and Kisqali are tied at 3.5 out of 5 by our independent rating.

What is the difference between Calquence and Kisqali?

Calquence contains Acalabrutinib, while Kisqali contains Ribociclib Succinate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.